Antibiotic Utilization in Medicaid-Enrolled Children: Associations with Medical Complexity

Kathleen D Snow1, Matthew Hall2, Jay G Berry1

  • 1Division of General Pediatrics, Department of Pediatrics, Boston Children's Hospital, Boston, MA.

Insights

Pediatric antibiotic use is higher in children with complex chronic conditions (CCCs). These children may benefit from targeted antibiotic stewardship interventions to reduce exposure and broad-spectrum antibiotic use.

Area of Science:

  • Pediatric pharmacology
  • Public health
  • Infectious disease epidemiology

Background:

  • Antibiotic utilization in pediatric populations requires ongoing monitoring.
  • Understanding factors influencing antibiotic prescribing is crucial for effective stewardship.
  • Children with complex chronic conditions (CCCs) may have unique patterns of antibiotic use.

Purpose of the Study:

  • To characterize current pediatric outpatient antibiotic prescribing patterns.
  • To identify patient-specific factors linked to high antibiotic consumption.
  • To inform targeted antibiotic stewardship initiatives.

Main Methods:

  • Retrospective cohort study utilizing Medicaid prescription claims data (2023).
  • Inclusion of children aged 0-18 years with continuous Medicaid enrollment.
  • Analysis of antibiotic fill rates and high utilization (>50 antibiotic days/year) using multivariable logistic regression.

Main Results:

  • 39.1% of 2.36 million Medicaid-enrolled children filled >1 antibiotic prescription.
  • Antibiotic rates increased significantly with medical complexity, from 514 to 2,882 per 1,000 persons for no vs. ≥3 CCCs.
  • High antibiotic use was associated with younger age, female sex, disability status, capitated plans, and increasing CCCs.

Conclusions:

  • Children with multiple CCCs exhibit substantially elevated antibiotic exposure.
  • Greater use of broad-spectrum antibiotics is observed in children with higher medical complexity.
  • This population represents an underrecognized group for antibiotic stewardship interventions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...